News
05-24-2020, 08:17 AM
Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, as compared with patients without these mutations.
More... (https://www.news-medical.net/news/20200522/Platinum-based-chemotherapy-may-improve-outcomes-for-some-metastatic-pancreatic-cancer-patients.aspx)
More... (https://www.news-medical.net/news/20200522/Platinum-based-chemotherapy-may-improve-outcomes-for-some-metastatic-pancreatic-cancer-patients.aspx)